Zura Bio Inc.
- Address
- 1489 West Warm Springs Road
Sponsor Overview
Specializations
Inflammatory Skin Disease
Clinical research in hidradenitis suppurativa focuses on reducing inflammatory lesions and improving disease control in adults living with chronic, recurrent skin involvement. The sponsor’s work in this area centers on therapeutic evaluation for a condition marked by painful nodules, abscesses, and scarring.
- Hidradenitis suppurativa
- Inflammatory lesions
- Chronic dermatologic disease
These studies reflect interest in treatment options for persistent cutaneous inflammation and the clinical burden associated with localized skin disease.
Autoimmune Connective Tissue Disease
Research in systemic sclerosis addresses skin thickening and related manifestations of a fibrosing autoimmune disorder. The sponsor’s trials examine therapeutic effects in a disease that can affect the skin and multiple organ systems.
- Systemic sclerosis
- Skin thickening
- Autoimmune fibrosis
This area highlights interest in conditions where immune dysregulation and progressive tissue remodeling contribute to long-term morbidity.
Immunology and Inflammation
The sponsor’s clinical program is concentrated in immune-mediated disease, with attention to inflammatory pathways that drive both dermatologic and fibrotic disorders. The therapeutic focus spans conditions in which immune activity contributes to persistent tissue damage and symptom burden.
- Immune-mediated disease
- Inflammatory pathways
- Fibrotic disease
These research interests align with therapies intended to address abnormal immune activation in chronic nonmalignant conditions.
Clinical Development in Rare and Chronic Disease
The sponsor is active in clinical development for chronic, specialized conditions with significant unmet need, including disorders managed across multiple research sites and countries. Its portfolio includes studies in diseases that require ongoing assessment of efficacy and tolerability in adult populations.
- Chronic disease management
- Adult patient populations
- Multinational clinical research
Current activity spans multiple regions and site networks supporting research in dermatology and systemic autoimmune disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults with Systemic Sclerosis |  Hungary Poland Romania Spain | Not Recruiting |
| Efficacy, Safety, and Tolerability of Tibulizumab in Adults with Hidradenitis Suppurativa: A Phase 2 Randomized, Placebo-Controlled, Multi-Center Study |  Germany Hungary Poland Spain | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 41 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
Partnered Research Centres
41 centres- Address
- Ul. Marii Konopnickiej 4, 82-200 Malbork
- Address
- Ul. Tadeusza Szafrana 5d / U2-U5, 30-363 Krakow
- Address
- Al. Wilanowska 333, 02-665 Warsaw
- Address
- Ul. Tarnopolska 77, 41-807 Zabrze
- Address
- Ul. Warszawska 5/7, 35-205 Rzeszów
- Address
- Paseo De La Castellana 261, 28046 Madrid
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Zura Bio Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.